Table 1.

Baseline clinical characteristics of all CML patients (n = 62) at diagnosis.

No. of patients	62
Males, No.	39
Females, No.	23
Age (years): median	53.73
WBC (x 10 9 /l): median	59.2
PLTS (x 10 9 /l): median	301.5
Hb (g/dl): median	11.6
Splenomegaly: median	05.8
Sokal risk: No.
Low	11
Intermediate	22
High	29
Hematological response at 3 months after imatinib initiation
CHR	36 (58.06%)
PHR	05 (8.06%)
No HR	21 (33.87%)